IL-1β 처리 백서 두개관 세포의 mineral trioxide aggregate에 대한 반응
Response of fetal rat calvarial cells on mineral trioxide aggregate after IL-1β stimulation
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Purpose: The purpose of this study was to investigate the ability of Mineral trioxide aggregate(MTA) to support osteoclastic differentiation from fetal rat calvarial cell. Methods: In this study, response of IL-6, RANKL, and OPG in fetal rat calvarial cells stimulated with IL-1β on MTA was evaluated by ELISA and RT-PCR. Results: The results were as follows; there was no significant difference between glass and MTA at 5days. In ELISA analysis, Glass group and MTA group showed similar IL-6 expression, Glass+IL-1β group and MTA+IL-1β group showed similar IL-6 expression. In RT-PCR analysis, Glass group and MTA group showed similar IL-6, RANKL, OPG mRNA expression, MTA+IL-1β group and Glass+IL-1β group showed 3 fold increase of IL-6 and RNAKL mRNA expression when compared with MTA group. All groups showed similar OPG mRNA expression. Conclusions: MTA does not suppress cell proliferation and increase the proinflammatory cytokine that induce osteoclastogenesis. Thus, MTA is biocompatible material that could be used in various clinical conditions. (J Korean Acad Periodontol 2009;39:359-365)
Abstract
Purpose: The purpose of this study was to investigate the ability of Mineral trioxide aggregate(MTA) to support osteoclastic differentiation from fetal rat calvarial cell. Methods: In this study, response of IL-6, RANKL, and OPG in fetal rat calvarial cells stimulated with IL-1β on MTA was evaluated by ELISA and RT-PCR. Results: The results were as follows; there was no significant difference between glass and MTA at 5days. In ELISA analysis, Glass group and MTA group showed similar IL-6 expression, Glass+IL-1β group and MTA+IL-1β group showed similar IL-6 expression. In RT-PCR analysis, Glass group and MTA group showed similar IL-6, RANKL, OPG mRNA expression, MTA+IL-1β group and Glass+IL-1β group showed 3 fold increase of IL-6 and RNAKL mRNA expression when compared with MTA group. All groups showed similar OPG mRNA expression. Conclusions: MTA does not suppress cell proliferation and increase the proinflammatory cytokine that induce osteoclastogenesis. Thus, MTA is biocompatible material that could be used in various clinical conditions. (J Korean Acad Periodontol 2009;39:359-365)
참고문헌 (22)
- Torabinejad M, "Physical and chemical properties of a new root-end filling material", J Endod, 21, pp.349~353 (1995)
- Koh ET, "Torabinejad M. Cellular response to Mineral Trioxide Aggregate", J Endod, 24, pp.543~547 (1998)
- Robert HW, "Mineral trioxide aggregate material use in endodontic treatment: a review of the literature", Dent Mater, 24, pp.149~164 (2008)
- Zhu Q, "Adhesion of human osteoblasts on root-end filling materials", J Endod, 26, pp.404~406 (2000)
- Torabinejad M, "Cytotoxicity of four root-end filling materials", J Endod, 21, pp.489~492 (1995)
- Pelliccioni GA, "Evaluation of osteoblast-like cell response to ProRoot MTA cement", J Mat Sci, 15, pp.167~173 (2004)
- Yavuzyilmaz E, "The gingival crevicular fluid interleukin-1beta and tumor necrosis factor-a levels in patients with rapidly progressive periodontitis", Aust Dent J, 40, pp.46~49 (1995)
- Tsai CC, "Levels of interleukin-1beta and interleukin-8 in gingival crevicular fluid in adult periodontitis", J Periodontol, 66, pp.852~859 (1995)
- Ishihara Y, "Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites", J Periodont Res, 32, pp.524~529 (1997)
- Giannopoulou C, "Effect of inflammation, smoking, and stress on gingival, crevicular fluid cytokine level", Journal of Clinical Periodontology, 30, pp.145~153 (2003)
- Barrieshi-Nusair K, "A prospective clinical study of mineral trioxide aggregate for partial pulpotomy in cariously exposed permanent teeth", J Endod, 32, pp.731~735 (2006)
- Cory AH, "Use of an aqueous soluble tetrazolium", formazan assay for cell growth assays in culture, 1991, pp.3, 207~212
- Nakayama A, "Behaviour of bone marrow osteoblasts-like cells on mineral trioxide aggregate: morphology and expression of type 1 collagen and bone-related protein mRNAs", Int Endodont J, 38, pp.203~210 (2005)
- Nakashima T, "Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand : Modulation of the expression by osteotropic factors and cytokines", Biochem Biophys Res Commun, 275, pp.768~775 (2000)
- Hofbaur LC, "Role of receptor activator of nuclear factor-kB ligand and osteoprotegerin in bone cell biology", J Mol Med, 79, pp.243~253 (2001)
- Siggelkow H, "Cytokine, osteoprotegerin, and RANKL in vitro and histomorphometric indices of bone turnover in patients with different bone disease", J Bone Miner Res, 18, pp.529~538 (2003)
- Kobayashi N, "Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis", EMBO J, 20, pp.1271~1280 (2001)
- Lerner UH, "Inflammation-induced bone remodeling in periodontal disease and the influence of post menopausal osteoporosis", J Dent Res, 85, pp.596~607 (2006)
- Boyle WJ, "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
- Cochran DL, "Inflammation and bone loss in periodontal disease", J Periodontol, 79, pp.1569~1576 (2008)
- Ishihara K, "IL-6 in autoimmune disease and chronic inflammatory proliferative disease", Cytoline Growth Factor Rev, 13, pp.357~368 (2002)
- Dalrymple SA, "Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection", Infect Immun, 64, pp.3231~3235 (1996)